14-day Premium Trial Subscription Try For FreeTry Free
FRA:RGO
Delisted

Regeneron Pharmaceuticals, Inc. Stock Signals

786.00€
+0 (+0%)
At Close: Dec 21, 2023

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 514 days ( -47.36 % )
Last Price 786.00€ 0 %
High/ Low 786.00€ - 786.00€ 0%
Chg 7 Days N/A $786.00 786.00€
Chg 30 Days N/A $786.00 786.00€
Chg 12 mos 13.39 % $693.20 786.00€
Trend - 3 mos 0.236 % Width: 2.19 %
Trend - 12 mos 15.66 % Width: 23.71 %
Pred. range - 3 mos 776.16€ - 793.17€ -1.25 % - 0.91 %
Pred. range - 12 mos 794.06€ - 982.30€ 1.03 % - 24.97 %
Short MA avg 3 mos Sell Oct 03, 2023 - 58 days
Long MA avg 3 mos Sell Nov 10, 2023 - 30 days
Short/Long MA avg 3 mos Sell Nov 10, 2023 - 30 days
Short MA avg 12 mos Sell Oct 23, 2023 - 44 days
Long MA avg 12 mos Buy Aug 02, 2023 - 102 days
Short/Long MA avg 12 mos Buy Aug 18, 2023 - 90 days
Pivot Short Sell Sep 26, 2023 - 63 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals. Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macular edema following retinal vein occlusion, including macular edema following central retinal vein occlus... RGO.F Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT